Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TROVAN/ZITHROMAX COMPLIANCE PAK

AZITHROMYCIN DIHYDRATE; TROVAFLOXACIN MESYLATE

Standard Dose
EQ 1GM BASE,N/A;N/A,EQ 100MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TROVAN/ZITHROMAX COMPLIANCE PAK is listed in Drugs@FDA under application 050762 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient AZITHROMYCIN DIHYDRATE; TROVAFLOXACIN MESYLATE Form and strength FOR SUSPENSION, TABLET;ORAL - EQ 1GM BASE,N/A;N/A,EQ 100MG BASE Sponsor PFIZER Submission history Latest submission status date: 1998-12-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview TROVAN/ZITHROMAX COMPLIANCE PAK is listed in Drugs@FDA under application 050762 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AZITHROMYCIN DIHYDRATE; TROVAFLOXACIN MESYLATE Form and strength FOR SUSPENSION, TABLET;ORAL - EQ 1GM BASE,N/A;N/A,EQ 100MG BASE Sponsor PFIZER Submission history Latest submission status date: 1998-12-18 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: Discontinued
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
TROVAN/ZITHROMAX COMPLIANCE PAK (AZITHROMYCIN DIHYDRATE; TROVAFLOXACIN MESYLATE) | Drug Monograph | MedicHelpline